Alterity Therapeutics (ATHE) Interest & Investment Income (2017 - 2025)
Alterity Therapeutics (ATHE) recorded quarterly Interest & Investment Income of $597319.6 in Q4 2025, up 720.67% quarter-over-quarter from $72784.7 in Q4 2024, and up 720.67% on a YoY basis from $72784.7 in Q4 2024.
Alterity Therapeutics (ATHE) Interest & Investment Income (2017 - 2025) Analysis & Trends
Alterity Therapeutics' Interest & Investment Income history runs 9 years deep, the most recent figure standing at $597319.6 for Q4 2025.
- In Q4 2025, Interest & Investment Income rose 720.67% year-over-year to $597319.6; the TTM figure through Dec 2025 stood at $597319.6 (up 720.67% YoY), while the FY2025 annual figure was $285819.6, up 61.58% from the prior year.
- Interest & Investment Income was $597319.6 for Q4 2025 at Alterity Therapeutics, up from $72784.7 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $597319.6 in Q4 2025 to a low of $983.48 in Q4 2021.
- Historically, Interest & Investment Income has averaged $151128.3 across 5 years, with a median of $72784.7 in 2024.
- The sharpest annual moves came in 2021 and 2023: Interest & Investment Income sank 79.47% in 2021, then soared 930.96% in 2023.
- A 5-year view of Interest & Investment Income shows it stood at $983.48 in 2021, then surged by 660.19% to $7476.3 in 2022, then jumped by 930.96% to $77077.3 in 2023, then fell by 5.57% to $72784.7 in 2024, then jumped by 720.67% to $597319.6 in 2025.
- The last three Interest & Investment Income figures came in at $597319.6 (Q4 2025), $72784.7 (Q4 2024), and $77077.3 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 597,319.59 |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -14.79 Mn |
| 10 | Regeneron Pharmaceuticals | 66.09 Bn | 57.33 Bn | 3.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 597,319.59 |
| Dec 31, 2024 | 72,784.72 |
| Dec 31, 2023 | 77,077.27 |
| Dec 31, 2022 | 7,476.25 |
| Dec 31, 2021 | 983.48 |
| Dec 31, 2020 | 4,789.82 |
| Dec 31, 2019 | 9,655.51 |
| Dec 31, 2018 | 47,609.30 |
| Dec 31, 2017 | 90,106.71 |